BioTechGrid – Page 334

Artificial intelligence could make autism screening more accessible

July 29, 2026

video: Using video from a standard camera, the AI tool automatically tracks a child’s movements as they imitate an instructor performing…

Biotechnology

Targeting a signaling pathway activated by acidic tumor environment restores treatment response to PARP inhibitors in ovarian cancer

July 29, 2026

image: Rugang Zhang, Ph.D. view more Credit: The University of Texas MD Anderson Cancer Center PARP inhibitors are among the most widely…

Biotechnology

UMBC researcher to build on HIV drug side effect research with new NIAID grant to improve HIV prevention drugs

July 29, 2026

A University of Maryland, Baltimore County (UMBC) scientist has received a two-year grant from the National Institute of Allergy and…

Genetics

Genetic Study of Fibromyalgia Points to Neurological Basis

July 29, 2026

Credit: CIPhotos / iStock / Getty Images An international team of researchers has identified multiple new genetic risk factors associated…

Genetics

Base Editing Strategy Alleviates Huntington’s Disease in Mice

July 29, 2026

Credit: AnnaStills/ iStock/ Getty Images Plus According to at least one estimate, approximately 41,000 people in the United States have…

Genetics

Landmark Phase III Trial Finds Cell Therapy Slows Muscle Decline in Advanced DMD

July 29, 2026

Cell therapy [wildpixel / iStock / Getty Images Plus] Duchenne muscular dystrophy (DMD) is an X-linked genetic disease that causes…

Genetics

Celonic and Leukocare Collaborate to Support Complex Biologics and Advanced Drug Development

July 29, 2026

Credit: Jackyenjoyphotography / Moment / Getty Images Celonic, a Swiss-based biologics CDMO, and Leukocare, which provides drug product development services,…

Biotechnology

FDA adcomm shoots down Capricor’s Duchenne cell therapy after meeting marked by statistical dispute

July 29, 2026

A panel of experts today voted against Capricor’s cell therapy for Duchenne muscular dystrophy, capping off an advisory committee meeting…

Biotechnology

In vivo CRISPR base editing for treatment of Huntington’s disease

July 29, 2026

Shirguppe, S., Gapinske, M., Swami, D. et al. In vivo CRISPR base editing for treatment of Huntington’s disease. Nat. Biomed.…

Biotechnology

Comment on: ‘Modelled impact of a multi-cancer early detection screening programme on cancer treatment in England

July 29, 2026

Zhang, R., Wei, Z. Comment on: ‘Modelled impact of a multi-cancer early detection screening programme on cancer treatment in England’.…

Lightweight AI Reads Brain Tumor Scans and Knows When It Is Unsure

Blood Type Offers No Shield Against Common Skin Warts, Study Finds

New AI Framework Blends Infrared and Visible Images by Seeing Others and Focusing Itself

Sick Leeches Keep Their Microbial Diversity but Lose Their Microbial Stability

Brain Tumor Biomarker Survives Tough Test: MGMT Signal Holds After Batch Effect Scrutiny

UTHealth Houston Scientist Wins $12 Million to Probe Brain Energy and Aging

Exploring the Future of Healthcare with Panos Karelis

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

Artificial intelligence could make autism screening more accessible

Targeting a signaling pathway activated by acidic tumor environment restores treatment response to PARP inhibitors in ovarian cancer

UMBC researcher to build on HIV drug side effect research with new NIAID grant to improve HIV prevention drugs

Genetic Study of Fibromyalgia Points to Neurological Basis

Base Editing Strategy Alleviates Huntington’s Disease in Mice

Landmark Phase III Trial Finds Cell Therapy Slows Muscle Decline in Advanced DMD

Celonic and Leukocare Collaborate to Support Complex Biologics and Advanced Drug Development

FDA adcomm shoots down Capricor’s Duchenne cell therapy after meeting marked by statistical dispute

In vivo CRISPR base editing for treatment of Huntington’s disease

Comment on: ‘Modelled impact of a multi-cancer early detection screening programme on cancer treatment in England

VertigoDx on firm ground with FDA greenlight for vertigo diagnostic system

Precision Neuroscience taps $250M in Series D funding for brain-computer interface

VC Sofinnova reels in €82M to target medtechs in the next 5 years

Adagio Medical kicks off strategic review, trims more than half its staff